- Home
- KPRX vs ARTW Comparison
KPRX vs ARTW Comparison
Compare KPRX & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPRX | ARTW |
|---|---|---|
| Founded | 1998 | 1956 |
| Country | United States | United States |
| Employees | 13 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7M | 13.4M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | KPRX | ARTW |
|---|---|---|
| Price | $2.46 | $2.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 20.9K | 11.1K |
| Earning Date | 05-08-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 233.33 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $22,975,408.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $61.75 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.76 | $2.05 |
| 52 Week High | $3.29 | $4.69 |
Technical Indicators
Market Signals| Indicator | KPRX | ARTW |
|---|---|---|
| Relative Strength Index (RSI) | 44.79 | 32.32 |
| Support Level | $2.44 | $2.07 |
| Resistance Level | $2.72 | $2.52 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 22.58 | 0.00 |
Price Performance
Historical ComparisonAbout KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.